Predictions, in date order.
22,747 predictions from 659 pundits.
The forthcoming Fall 2026 monotherapy update is a critical inflection point.
Additional data from the MICVO–pembrolizumab combination in first‑line HNSCC, expected in Q4 2026, provides a second major catalyst.
Nayax's stock price will remain at $75.
✗ WrongSanjay Sakhranimade August 14, 2026 · due Aug 14, 2027 (12 months assumed)Finance & Markets⚑ FlagEvidence audit →
Yatin Suneja predicts a price target of $55.00 for Zenas BioPharma within 12 months after reiterating the rating.
Cisco Systems will reach a price of $150 within 12 months of Aug 13, 2026.
Pelagos Insurance will maintain an Equal-Weight rating with a price target of $24.
Pelagos Insurance Capital will reach a price of $23 within 12 months of Aug 13, 2026.
Cerebras Systems will reach a price of $320.
We would have the best five-year earnings growth by a good chunk of any period over the course of the entire post-World War II era.
They’d have to move their savings rate to something like -15% over the course of the next five years.